$COLL
Collegium Pharmaceutical, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$22.77
▲+1.74%+$0.390
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCollegium Pharmaceutical, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is COLL up today? It is at $22.77 (+1.74%), and our scanner flagged it 62 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment COLL spikes, and full due diligence on COLL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $COLL 62 times in the last 30 days. Create a free account to track $COLL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on COLL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for COLL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Santini Gino Director | Other | 9K 0.03% of company | added 8.4% | 112K | $143K at $16.49 | Jun 8, 26 |
Freund John Gordon Director | Sold (automatic/other) | -20 | sold <0.1% | 84K | $681 at $34.05 | May 18, 26 |
Freund John Gordon Director | Sold (automatic/other) | -4K 0.01% of company | sold 4.7% | 84K | $143K at $34.54 | May 15, 26 |
Freund John Gordon Director | Other | 9K 0.03% of company | added 11% | 88K | $143K at $16.49 | May 15, 26 |
Glancy Donovan Michael Director | Acquired (grant/award) | +17K 0.05% of company | n/a | 17K | n/a | May 14, 26 |
Balice-Gordon Rita J. Director | Acquired (grant/award) | +9K 0.03% of company | added 17% | 61K | n/a | May 14, 26 |
Santini Gino Director | Acquired (grant/award) | +9K 0.03% of company | added 9.2% | 104K | n/a | May 14, 26 |
Freund John Gordon Director | Acquired (grant/award) | +9K 0.03% of company | added 12% | 79K | n/a | May 14, 26 |
Bohlin Garen G Director | Acquired (grant/award) | +9K 0.03% of company | added 14% | 71K | n/a | May 14, 26 |
Lurker Nancy Director | Acquired (grant/award) | +9K 0.03% of company | added 49% | 27K | n/a | May 14, 26 |
Paya Carlos V Director | Acquired (grant/award) | +9K 0.03% of company | added 45% | 28K | n/a | May 14, 26 |
Lurker Nancy Director | Sold (automatic/other) | -5K 0.01% of company | sold 20% | 18K | $162K at $35.97 | May 13, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on COLL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for COLL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
COLL last traded at $22.77, up 1.74% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Collegium Pharmaceutical, Inc. Common Stock (COLL) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The COLL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged COLL 62 times in the last 30 days.
COLL (Collegium Pharmaceutical, Inc. Common Stock) trades on XNAS, with a market cap of about $741M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge COLL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$COLL discussion
Sign in to ask a question or join the discussion.